Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.21873/invivo.11947 http://scihub22266oqcxt.onion/10.21873/invivo.11947 32503815!8378032!32503815     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       In+Vivo 2020 ; 34 (3 Suppl): 1589-1592 Nephropedia Template TP {{tp|p=32503815|t=2020. Role of Interleukin-6 in Lung Complications in Patients With COVID-19: Therapeutic Implications |pdf=|usr=}}{{32503815}} gab.com Text Role of Interleukin-6 in Lung Complications in Patients With COVID-19: Therapeutic Implications JO: In Vivo http://www.kidney.de/pget.php?&tw=1&pmid=32503815 #FOAvip COVID-19 is viral respiratory infection with frequently fatal lung complications in the elderly or in people with serious comorbidities. Lung destruction appears to be associated with a cytokine storm related to an increased level of interleukin-6 (IL6). Therapeutic targeting of the interleukin-6 signaling pathway can attenuate such a cytokine storm and can be beneficial for patients with COVID-19 in danger of pulmonary failure. This article demonstrates the importance of IL6 in progression of disease and the possibility of inhibition of IL6 signaling in COVID-19 therapy. Twit Text FOAVip Role of Interleukin-6 in Lung Complications in Patients With COVID-19: Therapeutic Implications ????In Vivo http://www.kidney.de/pget.php?&tw=1&pmid=32503815 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32503815 #FOAvip English Wikipedia <ref>{{Cite pmid|32503815}}</ref> Role of Interleukin-6 in Lung Complications in Patients With COVID-19: Therapeutic Implications #MMPMID32503815 Smetana K Jr; Brabek J In Vivo 2020[Jun]; 34 (3 Suppl): 1589-1592 PMID32503815show ga COVID-19 is viral respiratory infection with frequently fatal lung complications in the elderly or in people with serious comorbidities. Lung destruction appears to be associated with a cytokine storm related to an increased level of interleukin-6 (IL6). Therapeutic targeting of the interleukin-6 signaling pathway can attenuate such a cytokine storm and can be beneficial for patients with COVID-19 in danger of pulmonary failure. This article demonstrates the importance of IL6 in progression of disease and the possibility of inhibition of IL6 signaling in COVID-19 therapy. |Anti-Inflammatory Agents/therapeutic use[MESH] |Antibodies, Monoclonal, Humanized/therapeutic use[MESH] |Antibodies, Monoclonal/therapeutic use[MESH] |Antiviral Agents/therapeutic use[MESH] |COVID-19[MESH] |Clinical Trials as Topic[MESH] |Coronavirus Infections/*complications/drug therapy/immunology/physiopathology[MESH] |Cytokine Receptor gp130/antagonists & inhibitors/physiology[MESH] |Cytokine Release Syndrome/drug therapy/*etiology/immunology/physiopathology[MESH] |Humans[MESH] |Immunotherapy[MESH] |Indoles/therapeutic use[MESH] |Interleukin-6/antagonists & inhibitors/*physiology[MESH] |Lung/pathology[MESH] |Pandemics[MESH] |Pneumonia, Viral/*complications/drug therapy/immunology/physiopathology[MESH] |Receptors, Interleukin-6/antagonists & inhibitors/physiology[MESH] |Receptors, Virus/drug effects[MESH]Role of Interleukin-6 in Lung Complications in Patients With COVID-19:(epmc).pdf DeepDyve Pubget Overpricing